Health
Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion – News-Medical.Net
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as nsp15 and optimized fluorescent biochemical endoribonuclease assays to screen a custom chemical library with over 5,000 commercial compounds. The study is currently available on the bioRxiv* preprint server.
SARS-CoV-2 is a causative agent of coronavirus disease 2019 (COVID-19), a human disease that resulted in millions…
-
General11 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News13 hours agoSanta drops in for carols
-
General16 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Business17 hours agoHow to turn small weekly savings into life-changing wealth with ASX shares